TranS1 Inc. Reports Operating Results for the Third Quarter of 2012, Issues Fourth Quarter 2012 Guidance
November 08, 2012 16:01 ET
|
Baxano Surgical, Inc.
- Third Quarter Revenues Were $3.2 Million -
- Net Loss Per Share Was $0.22 for the Quarter -
WILMINGTON, N.C., Nov. 8, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device...
TranS1 Inc. Announces Category I Physician Payment Rates for Single Level AxiaLIF Fusion
November 02, 2012 10:55 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Nov. 2, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products that implement its proprietary approach...
TranS1 Inc. Announces Participation at the 2012 Lazard Capital Markets Healthcare Conference
November 01, 2012 16:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Nov. 1, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief...
TranS1 Inc. Schedules Third Quarter 2012 Results Conference Call for Thursday, November 8, 2012
October 25, 2012 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Oct. 25, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release third quarter 2012 financial and operating results after market close on...
TranS1 Inc. Announces Distribution Agreement in China
October 10, 2012 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Oct. 10, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the...
TranS1 Inc. Announces Appointment of Stephanie M. Fitts, Ph.D. as Vice President of Regulatory, Quality and Compliance
September 17, 2012 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Sept. 17, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the...
TranS1 Inc. Announces Participation at the 2012 Stifel Nicolaus Healthcare Conference
August 28, 2012 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Aug. 28, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and...
TranS1 Inc. Reports Operating Results for the Second Quarter of 2012, Issues Third Quarter 2012 Guidance
August 09, 2012 16:01 ET
|
Baxano Surgical, Inc.
- Second Quarter Revenues Were $3.5 Million -
- Net Loss per Share Was $0.23 for the Quarter -
WILMINGTON, N.C., Aug. 9, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device...
TranS1 Inc. Announces Completion of First Retrospective Head-to-Head Fusion Rate Study
August 02, 2012 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Aug. 2, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a pioneer in minimally invasive approaches to lumbar spine surgery, today announced completion of the first head-to-head...
TranS1 Inc. Schedules Second Quarter 2012 Results Conference Call for Thursday, August 9, 2012
July 26, 2012 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., July 26, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release second quarter 2012 financial and operating results after market close on...